Cipla gets USFDA EIR for Invagen manufacturing facility Medical Dialogues Bureau29 Jan 2020 12:57 PM ISTNew Delhi: Homegrown pharma major Cipla on Tuesday said it has received a report from the US health regulator indicating closure of the inspection at...
Cipla gets USFDA observations for its Goa facility Medical Dialogues Bureau23 Jan 2020 3:23 PM ISTNew Delhi: Drug firm Cipla on Wednesday said it has received observations from the USFDA for its Goa manufacturing facility. It further said that the...
Japanese financial group MUFG sells 2.10pc shares in Cipla Medical Dialogues Bureau23 Jan 2020 10:00 AM IST "MUFG has sold an indirect interest in Cipla Ltd on account of sale of the following entities: First State Investment Management (UK) Ltd, First...
Cipla Patalganga facility gets EIR from USFDA Farhat Nasim20 Jan 2020 11:52 AM IST "Following the inspection by the United States Food and Drug Administration (USFDA) at the Patalganga manufacturing facility of the company from...
NPPA fixes price of Cipla Synchrobreathe inhaler device; Details Medical Dialogues Bureau22 Dec 2019 2:26 PM ISTNew Delhi: Price of Synchrobreathe inhaler device manufactured by pharma giant Cipla has been set at Rs 67.20 after the National Pharmaceutical...
NPPA fixes retail price of 44 combo drugs including Metformin, Vildagliptin, Paracetamol; Details Farhat Nasim20 Dec 2019 11:55 AM ISTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
NPPA fixes retail price of 12 combo drugs including Aspirin, Atorvastatin, Metformin; Details Farhat Nasim17 Nov 2019 1:08 PM ISTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details Medical Dialogues Bureau15 Nov 2019 4:29 PM ISTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
NPPA fixes retail price of 14 drug formulations; Details Farhat Nasim13 Nov 2019 11:23 AM ISTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
Cipla acquires novel anti-infective Elores to further antimicrobial stewardship in critical care in India Medical Dialogues Bureau18 Oct 2019 1:50 PM ISTMumbai: Cipla Limited announces the acquisition of a novel and patented anti-infective product, Elores, from Venus Remedies Limited ("VRL") for the...
Cipla gets 12 USFDA observations for Goa facility Medical Dialogues Bureau30 Sept 2019 3:15 PM IST"The United States Food and Drug Administration (USFDA) conducted a cGMP inspection at our Goa manufacturing facility from September 16-27, 2019,"...
Cipla launches skin treatment Daptomycin Injection in US Medical Dialogues Bureau27 Sept 2019 1:53 PM ISTDrug firm Cipla on Wednesday said it has launched Daptomycin Injection, used for treating complicated skin infections, in the US market. Daptomycin...
